The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Feasibility of Postexposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: The San Francisco PEP Study
Abstract
The feasibility of providing postexposure prophylaxis (PEP) after sexual or injection drug use exposures to human immunodeficiency virus (HIV) was evaluated. PEP was provided within 72 h to individuals with exposures from partners known to have or to be at risk for HIV infection. PEP consisted of 4 weeks of antiretroviral medications and individually tailored risk-reduction and medication-adherence counseling. Among 401 participants seeking PEP, sexual exposures were most common (94%; n=375). Among sexual exposures, receptive (40%) and insertive (27%) anal intercourse were the most common sexual acts. The median time from exposure to treatment was 33 h. Ninety-seven percent of participants were treated exclusively with dual reverse-transcriptase inhibitors, and 78% completed the 4-week treatment. Six months after the exposure, no participant developed HIV antibodies, although a second PEP course for a subsequent exposure was provided to 12%. PEP, after nonoccupational HIV exposure, is feasible for persons at risk for HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271
A case-control study of HIV seroconversion in health care workers after percutaneous exposure.
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372101 · Cited by 1,198
Kamb, M. L., Fishbein, M., Douglas, Jr., Rhodes, F., Rogers, J., Bolan, G., Zenilman, J., Hoxworth, T., Malotte, C. K., Iatesta, M., et al. (1998) · JAMA · doi:10.1001/jama.280.13.1161 · Cited by 973 · cited 1×
“The period immediately after an exposure to HIV is a unique opportunity for clinicians to provide education and counseling regarding the prevention of future exposures [36–38].”
BackgroundCoping effectiveness training for men living with HIV: Preliminary findings
Chesney, M., Folkman, S., & Chambers, D. (1996) · International Journal of STD & AIDS · doi:10.1258/0956462961917690 · Cited by 163
Self-citation
Cited by
Saul, J., Bachman, G., Allen, S., Toiv, N. F., Cooney, C., & Beamon, T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0208167 · Cited by 319
Ford, N., Venter, F., Irvine, C., Beanland, R. L., & Shubber, Z. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ093 · Cited by 38
Metadata
- Authors
- Kahn, J. O., Martin, J. N., Roland, M. E., Bamberger, J. D., Chesney, M., Chambers, D., Franses, K., Coates, T. J., & Katz, M. H.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-03
- Volume
- 183
- Issue
- 5
- Pages
- 707-714
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1995226511
- Cited by
- 172
- References
- 4
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Feasibility of Postexposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: The San Francisco PEP Study. https://app.cochat.ai/papers/10.1086/318829
- The paper
- Kahn, J. O., Martin, J. N., Roland, M. E., Bamberger, J. D., Chesney, M., Chambers, D., Franses, K., Coates, T. J., & Katz, M. H. (2001). Feasibility of Postexposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: The San Francisco PEP Study. The Journal of Infectious Diseases. https://doi.org/10.1086/318829
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.